Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating activities    
Net loss - including non-controlling interest $ (429,389) $ (368,363)
Adjustments to reconcile net loss to net cash used in operations    
Amortization of debt discount 9,098 5,688
Accreted interest on note receivable (3,308) (17,809)
Depreciation expense 80
Amortization of website development costs 1,336
Net loss from equity method investment 46,030 13,406
Unrealized loss on available - for - sale securities 231,183 20,500
Decrease (Increase) in    
Accounts receivable - related party (22,500)
Interest receivable (7,690) (4,923)
Prepaids 25,000
Increase in    
Accounts payable and accrued expenses 115,561 40,290
Accounts payable and accrued expenses - related party 60,000 60,000
Accumulated losses on unconsolidated investees in excess of investment 1,226 39,742
Net cash provided by (used in) operating activities 211 (185,053)
Investing activities    
Notes receivable (119,000)
Website development cost (9,500)
Net cash used in investing activities (128,500)
Financing activities    
Payment of convertible note payable (25,000)
Proceeds from issuance of convertible note payable, related party, net 50,000
Proceeds from short term advances, related parties 392,500
Net cash provided by financing activities 417,500
Net increase in cash 211 103,947
Cash and cash equivalents - beginning of period 227,558 5,632
Cash and cash equivalents - end of period 227,769 109,579
Supplemental disclosure of cash flow information    
Cash paid for interest 27,545
Cash paid for income tax
Supplemental disclosure of non-cash investing and financing activities    
Investment at fair value received from issuance of note receivable 43,000
Beneficial conversion features on convertible notes payable - related party 3,799
Notes receivable and interest receivable converted to shares $ 27,218